Class III drugs and congestive heart failure: Focus on the congestive heart failure-survival trial of antiarrhythmic therapy

American Journal of Cardiology

Volumn 84, Issue 9 SUPPL. 1, 1999, Pages 103-108

  Singh, Steven N ^a   Fletcher, Ross D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOFETILIDE; PLACEBO; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT; SOTALOL;

CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; IMPLANT; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL; TORSADE DES POINTES;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; HEART FAILURE, CONGESTIVE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0032702077     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00710-9     Document Type: Conference Paper

References (22)

1. Garg R., Packer M., Pitt B., Yusuf S. Heart failure in the 1990s evolution of a major public health problem in cardiovascular medicine . J Am Coll Cardiol. 22:(suppl A):1993;3A-5A.
2. Luu M., Stevenson W.G., Stevenson L.W., Baron K., Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 80:1989;1675-1680.
3. Grubman E.M., Pavri B.B., Shipman T., Britton N., Kocovic D.Z. Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol. 32:1998;1056-1062.
4. Flaker G.C., Blackshear J.L., McBride R., Kronmal R.A., Halperin J.L., Hart R.G. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol. 20:1992;527-532.
5. Waldo A.L., Camm A.J., de Ruyter H., Friedman P.L., MacNeil D.J., Pauls J.F., Pitt B., Pratt C.M., Schwartz P.J., Veltri E.P. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 348:1996;7-12.
6. Pratt C.M., Camm A.J., Cooper W., Friedman P.L., MacNeil D., Moulton F.M., Putt B., Schwartz P.J., Veltri E.P., Waldo A.L. Mortality in the Survival With ORal D-sotalol (SWORD) trial Why did patients die? Am J Cardiol. 81:1998;869-876.
7. Cleland J.G.F., Dargie H.J., Findlay I.N., Wilson J.T. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. Br Heart J. 57:1987;436-445.
8. Nicklas J.M., McKenna W.J., Stewart R.A., Mickelson J.K., Das S.K., Schork M.A., Krikler S.J., Quain L.A., Morady F., Pitt B. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J. 122:1991;1016-1021.
9. Pfisterer M., Kiowski W., Burckhardt D., Follath F., Burkart F. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol. 69:1992;1399-1402.
10. Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 344:1994;493-498.
11. Singh S.N., Fletcher R.D., Fisher S.G., Singh B.N., Lewis H.D., Deedwania P.C., Massie B.M., Colling C., Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 333:1995;77-82.
12. Massie B.M., Fisher S.G., Radford M., Deedwania P.C., Singh B.N., Fletcher R.D., Singh S.N. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation. 93:1996;2128-2134.
13. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure meta-analysis of individual data from 6500 patients in randomised trials . Lancet. 350:1997;1417-1424.
14. Moss A., Hall J., Cannom D., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
15. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
16. Kuck HK. Cardiac Arrest Study Hamburg (CASH). Presented at the ACC 1998.
17. Connally SJ. Canadian Implantable Defibrillator Study (CIDS). Presented at the ACC 1998.
18. + channels in the sarcoplasmic reticulum membranes. Pflügers Arch. 409:1987;374-380.
19. Gottlieb S.S., Singh S., Munger M., Eichhorn E., Ilgenfritz, Hanyok J. Hemodynamic effects of the Class III antiarrhythmic drug d-sotalol in patients with congestive heart failure. Am J Cardiol. 78:1996;1411-1415.
20. Deedwania P.C., Singh B.N., Ellenbogen K., Fisher J.G., Fletcher R.D., Singh S.N. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Circulation. 98:1998;2574-2578.
21. Pedersen O.D. Dofetilide in the treatment of atrial fibrillation in patients with impaired left ventricular function. (Abstr.) Eur Heart J. 19:1998.
22. Julian D.G., Camm A.J., Frangin G., Janse M.J., Munoz A., Schwartz P.J., Simon P. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction EMIAT . Lancet. 339:1997;667-674.